NCT00002085
Completed
Not Applicable
A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
ConditionsMycobacterium Avium-Intracellulare InfectionHIV InfectionsTuberculosis, Mycobacterium Infection
DrugsAzithromycin
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Mycobacterium Avium-Intracellulare Infection
- Sponsor
- Pfizer
- Locations
- 2
- Status
- Completed
- Last Updated
- 20 years ago
Overview
Brief Summary
To evaluate the efficacy and safety of azithromycin given chronically for the treatment of serious nontuberculous mycobacterial infection in patients failing or intolerant of other available therapy.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (2)
Loading locations...
Similar Trials
Unknown
Phase 4
Azithromycin in Hospitalized COVID-19 PatientsCOVID-19NCT04359316Shahid Beheshti University of Medical Sciences40
Completed
Not Applicable
Efficacy of Azithromycin as an Adjunct to Non-Surgical Periodontal TreatmentPeriodontitisNCT03629288Universidad Nacional Andres Bello18
Completed
Not Applicable
Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)PneumoniaPelvic Inflammatory DiseaseNCT01671280Pfizer403
Completed
Not Applicable
An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)Mycobacterium Avium-Intracellulare InfectionHIV InfectionsNCT00002090Pfizer
Terminated
Phase 2
Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast AsiaMalaria, FalciparumNCT00084240Pfizer32